Ledger.Open graph →

SEC Form D · Amendment · filed February 28, 2022

LexaGene Holdings Inc

Offering

$11.5M

Sold

$5.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BEVERLY, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

John (Jack) F. Regan · Beverly, MAExec · Director Stephen J. Mastrocola · Beverly, MADirector Jeffrey M. Mitchell · Beverly, MAExec Joseph M. Caruso · Beverly, MADirector Thomas R. Slezak · Beverly, MADirector Jane R. Sykes · Beverly, MADirector Steven Armstrong · Beverly, MAExec Gheorghe Rotar · TAMPA, FLDirector Matthew Stern · Los Angeles, CADirector Ron Lockhart · PAOLI, PAExec Ronald Redell · TAMPA, FLDirector Lee Fixel · New York, NYExec · Director Benjamin Taft · Los Angeles, CADirector Patrick Townzen · TAMPA, FLExec Gary Cohn · Cleveland, OHExec · Director Mark Froimson · Cleveland, OHExec Kevin D. Demeritt · Newport Beach, CADirector Luke V. Carlson · San Francisco, CADirector Kirk Wycoff · Brentwood, TNExec Sarah Biller · Brentwood, TNDirector John Philpott · Brentwood, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗